Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.

Life Sciences [q-bio] Microbiology and Parasitology Bacteriology Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Microbiology and Parasitology Parasitology Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system Life Sciences [q-bio] Human health and pathology Emerging diseases Life Sciences [q-bio] Human health and pathology Infectious diseases

Isabelle COMBE : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03215708

Submitted on : Monday, May 3, 2021-2:59:31 PM

Last modification on : Monday, March 20, 2023-3:30:10 PM

Dates and versions

hal-03215708 , version 1 (03-05-2021)

Identifiers

HAL Id : hal-03215708 , version 1
DOI : 10.1016/j.ijantimicag.2020.106237
PUBMEDCENTRAL : PMC7779261

Cite

Philippe Gautret, van Thuan Hoang, Jean-Christophe Lagier, Didier Raoult. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.. International Journal of Antimicrobial Agents, 2021, 57 (1), pp.106237. ⟨10.1016/j.ijantimicag.2020.106237⟩. ⟨hal-03215708⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU INCIAM

10 View

0 Download